PuSH - Publication Server of Helmholtz Zentrum München

78 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Fritsche, L. et al.: Incretin hypersecretion in gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 107, e2425-e2430 (2022)
2.
Hanschkow, M.* et al.: Expression of the adipocyte progenitor markers MSCA1 and CD36 is associated with adipose tissue function in children. J. Clin. Endocrinol. Metab. 107, e836-e851 (2022)
3.
Lehn-Stefan, A. et al.: Impaired metabolic health and low cardiorespiratory fitness independently associate with subclinical atherosclerosis in obesity. J. Clin. Endocrinol. Metab. 107, e2417-e2424 (2022)
4.
Li, Z.* et al.: Childhood height growth rate association with the risk of islet autoimmunity and development of type 1 diabetes. J. Clin. Endocrinol. Metab. 107, 1520-1528 (2022)
5.
Wang, M.* et al.: Circulating levels of microRNA-122 and hepatic fat change in response to weight-loss interventions: CENTRAL Trial. J. Clin. Endocrinol. Metab. 107, E1899-E1906 (2022)
6.
Dannecker, C. et al.: Low-density lipoprotein cholesterol is associated with insulin secretion. J. Clin. Endocrinol. Metab. 106, 1576-1584 (2021)
7.
Erlic, Z.* et al.: Targeted metabolomics as a tool in discriminating endocrine from primary hypertension. J. Clin. Endocrinol. Metab. 106, 1111-1128 (2021)
8.
Hörber, S. et al.: Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes. J. Clin. Endocrinol. Metab. 106, E3198-E3207 (2021)
9.
Krug, R.* ; Beier, L.* ; Lämmerhofer, M.* & Hallschmid, M.: Distinct and convergent beneficial effects of estrogen and insulin on cognitive function in healthy young men. J. Clin. Endocrinol. Metab. 107, e582-e593 (2021)
10.
Kullmann, S. et al.: Central insulin modulates dopamine signaling in the human striatum. J. Clin. Endocrinol. Metab. 106, 2949-2961 (2021)
11.
Lehn-Stefan, A. et al.: Elevated circulating glutamate associates with subclinical atherosclerosis independently of established risk markers: A cross-sectional study. J. Clin. Endocrinol. Metab. 106, e982-e989 (2021)
12.
Rottenkolber, M. et al.: A pathophysiology of type 2 diabetes unrelated to metabolic syndrome. J. Clin. Endocrinol. Metab. 106, 1460-1471 (2021)
13.
Thorand, B. et al.: A panel of six biomarkers significantly improves the prediction of type 2 diabetes in the MONICA/KORA study population. J. Clin. Endocrinol. Metab. 106, e1647-e1659 (2021)
14.
Bardugo, A.* et al.: Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood. J. Clin. Endocrinol. Metab. 106, e34-e44 (2020)
15.
Bornstein, S.R.* et al.: New horizons: Novel adrenal regenerative therapies. J. Clin. Endocrinol. Metab. 105, 3103-3107 (2020)
16.
Hoffmann, C.* et al.: Response of mitochondrial respiration in adipose tissue and muscle to 8 weeks of endurance exercise in obese subjects. J. Clin. Endocrinol. Metab. 105:dgaa571 (2020)
17.
Hu, C.* et al.: Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism. J. Clin. Endocrinol. Metab. 105, 1196–1209 (2020)
18.
Pozzilli, P.* et al.: Randomized 52-week phase 2 trial of albiglutide vs placebo in adult patients with newly diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 105, e2192–e2206 (2020)
19.
Randrianarisoa, E. et al.: AMPK subunits harbor largely non-overlapping genetic determinants for body fat mass, glucose- and cholesterol metabolism. J. Clin. Endocrinol. Metab. 105, 14-25:dgz020 (2020)
20.
Tofte, N.* et al.: Plasma metabolomics identifies markers of impaired renal function: A meta-analysis of 3,089 persons with type 2 diabetes. J. Clin. Endocrinol. Metab. 105:dgaa173 (2020)